Breaking News Instant updates and real-time market news.

GSK

GlaxoSmithKline

$42.46

-0.06 (-0.14%)

12:20
10/21/19
10/21
12:20
10/21/19
12:20

GlaxoSmithKline to divest rabies, tick-borne encephalitis vaccines

GlaxoSmithKline announced the divestment of travel vaccines Rabipur for the prevention of rabies, and Encepur for the prevention of tick-borne encephalitis, to Bavarian Nordic. The decision to divest these brands, acquired from Novartis in 2015 as part of the acquisition of its vaccines business, supports GSK's strategic intent to increase focus and reinvest in growth assets, innovation and a simplified supply chain in its vaccines business. GSK will receive an upfront payment of approximately EUR301M and will also receive milestone payments of EUR495M and additional proceeds from the sale of inventory over the course of the supply arrangements for a total consideration of up to EUR 955M. The value of inventory at the anticipated closing date is estimated to be EUR 159M. EUR 25M of the total consideration is conditional upon future sales performance of the two vaccines. Milestones are payable upon successful technology transfer, marketing authorization transfers and the fulfillment of GSK's supply commitments until Bavarian Nordic obtains regulatory approval to manufacture the vaccines. To ensure supply continuity both vaccines will continue to be manufactured primarily at GSK's Marburg site in Germany until full production is transferred to Bavarian Nordic. The staged technology transfer is expected to commence in Q1 2020 with completion anticipated within 5 years. No employees or manufacturing facilities are being transferred as part of this transaction. The transaction is expected to close by the end of 2019 and is conditional upon anti-trust approval as well as approval of Bavarian Nordic's rights issue by its shareholders.

  • 26

    Oct

  • 30

    Oct

  • 07

    Dec

GSK GlaxoSmithKline
$42.46

-0.06 (-0.14%)

09/04/19
COWN
09/04/19
NO CHANGE
Target $48
COWN
Outperform
Pfizer shares remain attractively valued, says Cowen
Cowen analyst Steve Scalia updated his Pfizer (PFE) model following Q2 results, the closing of the Glaxo (GSK) Consumer joint venture, and the announcement that its Upjohn business would be divested and combined with Mylan (MYL). The analyst lowered his estimates to reflect what is left at the company and despite his revision feels the shares remain attractively valued. Scalia reiterated his Outperform rating and $48 price target on Pfizer shares.
10/11/19
CANT
10/11/19
UPGRADE
CANT
Overweight
GlaxoSmithKline upgraded to Buy from Hold at Cantor Fitzgerald
Cantor Fitzgerald analyst Brian White upgraded GlaxoSmithKline to Buy from Hold with a price target of 2,000 pence.
10/11/19
CANT
10/11/19
UPGRADE
CANT
Overweight
Cantor upgrades GSK to Buy on reinvigoration of cancer franchise
Cantor Fitzgerald analyst Brian White upgraded GlaxoSmithKline to Buy from Hold with a price target of 2000 pence, up from 1450 pence. The Novartis transactions bolstered GSK's Vaccines and Consumer businesses at the expense of Pharma, while recent events have served to continue the theme while reinvigorating the cancer franchise, White tells investors in a research note. The analyst believes GSK has access to differentiated oncology products, "which promise to form a cornerstone for future franchise building." Further, consummation of the Consumer business should drive greater profitability "but Pharma has a narrow window to build a sustainable late stage pipeline," he adds.
10/16/19
NWST
10/16/19
UPGRADE
NWST
Neutral
GlaxoSmithKline upgraded to Hold from Reduce at New Street

TODAY'S FREE FLY STORIES

GOOG

Alphabet

$1,298.76

-10.6 (-0.81%)

, GOOGL

Alphabet Class A

$1,297.98

-10 (-0.76%)

17:05
11/11/19
11/11
17:05
11/11/19
17:05
Periodicals
State AGs gather in Colorado to go over Google antitrust probe, Reuters says »

State attorneys general…

GOOG

Alphabet

$1,298.76

-10.6 (-0.81%)

GOOGL

Alphabet Class A

$1,297.98

-10 (-0.76%)

FB

Facebook

$189.57

-1.29 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNV

Franco-Nevada

$95.70

0.09 (0.09%)

17:03
11/11/19
11/11
17:03
11/11/19
17:03
Hot Stocks
Franco-Nevada reports 133,219 Gold Equivalent Ounces sold in Q3 »

"Franco-Nevada's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

FNV

Franco-Nevada

$95.70

0.09 (0.09%)

17:02
11/11/19
11/11
17:02
11/11/19
17:02
Earnings
Franco-Nevada reports Q3 EPS 54c, may not compare to consensus 27c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ENR

Energizer

$43.11

-0.265 (-0.61%)

16:55
11/11/19
11/11
16:55
11/11/19
16:55
Hot Stocks
Energizer appoints new CFO, Chief Legal Officer, and Chief Accounting Officer »

Energizer Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 21

    Nov

LYV

Live Nation

$64.47

1.31 (2.07%)

16:52
11/11/19
11/11
16:52
11/11/19
16:52
Upgrade
Live Nation rating change  »

Live Nation upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BUD

AB InBev

$78.70

0.22 (0.28%)

, BREW

Craft Brew

$7.33

0.06 (0.83%)

16:51
11/11/19
11/11
16:51
11/11/19
16:51
Hot Stocks
Anheuser-Busch to buy remaining Craft Brew Alliance stake for $16.50 per share »

Today, Craft Brew…

BUD

AB InBev

$78.70

0.22 (0.28%)

BREW

Craft Brew

$7.33

0.06 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 13

    Nov

  • 27

    Feb

CHAP

Chaparral Energy

$0.90

0.089 (10.99%)

16:47
11/11/19
11/11
16:47
11/11/19
16:47
Earnings
Chaparral Energy reports Q3 EPS ($2.86), consensus 2c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

DXC

DXC Technology

$29.39

-0.69 (-2.29%)

16:43
11/11/19
11/11
16:43
11/11/19
16:43
Hot Stocks
DXC Technology says will pursue strategic alternatives for adjacent business »

In Q2 presentation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

DXC

DXC Technology

$29.39

-0.69 (-2.29%)

16:41
11/11/19
11/11
16:41
11/11/19
16:41
Earnings
DXC Technology cuts FY20 EPS view to $5.25-$5.75 from $7.00-$7.75 »

Consensus $7.17. Cuts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

LONE

Lonestar Resources

$2.88

0.08 (2.86%)

16:35
11/11/19
11/11
16:35
11/11/19
16:35
Hot Stocks
Lonestar sees Q4 production 17,200-17,600 BOE/d »

Lonestar has issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

NFE

New Fortress Energy

$15.86

-0.88 (-5.26%)

16:34
11/11/19
11/11
16:34
11/11/19
16:34
Earnings
New Fortress Energy reports Q3 EPS (30c), consensus (16c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 04

    Dec

TME

Tencent Music

$14.35

0.36 (2.57%)

16:34
11/11/19
11/11
16:34
11/11/19
16:34
Hot Stocks
Tencent Music reports Q3 online music Mobile MAUs up 0.9% »

Reports Q3: Mobile MAU up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

LONE

Lonestar Resources

$2.88

0.08 (2.86%)

16:33
11/11/19
11/11
16:33
11/11/19
16:33
Earnings
Lonestar has issued production guidance of 17,200 to 17,600 BOE/d for 4Q19. Prod »

Lonestar has issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

FEDU

Four Seasons Education

$2.08

0.09 (4.52%)

16:33
11/11/19
11/11
16:33
11/11/19
16:33
Hot Stocks
Four Seasons Education appoints Yi Zuo CEO »

Four Seasons Education…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LONE

Lonestar Resources

$2.88

0.08 (2.86%)

16:32
11/11/19
11/11
16:32
11/11/19
16:32
Earnings
Lonestar reports Q3 EPS 33c, may not compare to consensus (4c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

TME

Tencent Music

$14.35

0.36 (2.57%)

16:32
11/11/19
11/11
16:32
11/11/19
16:32
Hot Stocks
Tencent Music reports Q3 online music payers up 42.2% at 35.4M »

CEO Cussion Pang says:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

TME

Tencent Music

$14.35

0.36 (2.57%)

16:31
11/11/19
11/11
16:31
11/11/19
16:31
Earnings
Tencent Music reports Q3 EPS 10c, consensus 9c »

Reports Q3 revenue $910M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

KKR

KKR

$29.27

0.14 (0.48%)

, WBA

Walgreens Boots Alliance

$62.26

3.06 (5.17%)

16:31
11/11/19
11/11
16:31
11/11/19
16:31
On The Fly
Fly Intel: Wall Street's top stories for Monday »

Stocks were generally…

KKR

KKR

$29.27

0.14 (0.48%)

WBA

Walgreens Boots Alliance

$62.26

3.06 (5.17%)

EVR

Evercore Partners

$77.16

-1.14 (-1.46%)

BABA

Alibaba

$186.71

-0.4 (-0.21%)

LUV

Southwest

$58.27

0.1 (0.17%)

BA

Boeing

$366.97

16.32 (4.65%)

AAL

American Airlines

$30.58

-0.19 (-0.62%)

OTEX

OpenText

$42.54

0.99 (2.38%)

CARB

Carbonite

$22.93

4.54 (24.69%)

WE

We Company

$0.00

(0.00%)

TMUS

T-Mobile

$79.64

-1.28 (-1.58%)

S

Sprint

$5.91

-0.2 (-3.27%)

GOOG

Alphabet

$1,298.89

-10.47 (-0.80%)

GOOGL

Alphabet Class A

$1,298.21

-9.77 (-0.75%)

AAPL

Apple

$262.16

1.96 (0.75%)

AGEN

Agenus

$3.90

0.325 (9.10%)

URGN

UroGen Pharma

$24.16

0.59 (2.50%)

PLUG

Plug Power

$2.93

0.205 (7.54%)

MYOK

MyoKardia

$55.48

-4.51 (-7.52%)

SGMS

Scientific Games

$29.85

-1.74 (-5.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 11

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 18

    Nov

  • 19

    Nov

  • 22

    Nov

  • 09

    Dec

  • 12

    Dec

  • 23

    Jan

BEN

Franklin Resources

$27.95

-0.33 (-1.17%)

16:31
11/11/19
11/11
16:31
11/11/19
16:31
Hot Stocks
Franklin Resources reports preliminary AUM $693.1B as of October 31 »

Compared to $692.6B at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APYX

Apyx Medical

$7.23

0.25 (3.58%)

16:30
11/11/19
11/11
16:30
11/11/19
16:30
Earnings
Apyx Medical raises FY19 revenue view to $27.4M-$27.9M from $26.5M-$27.5M »

Consensus $26.97M. Sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 12

    Nov

RETA

Reata Pharmaceuticals

$213.50

1.46 (0.69%)

16:30
11/11/19
11/11
16:30
11/11/19
16:30
Hot Stocks
Breaking Hot Stocks news story on Reata Pharmaceuticals »

Reata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

16:30
11/11/19
11/11
16:30
11/11/19
16:30
Options
Preliminary option volume of 14.8M today »

Preliminary option volume…

APYX

Apyx Medical

$7.23

0.25 (3.58%)

16:28
11/11/19
11/11
16:28
11/11/19
16:28
Earnings
Apyx Medical reports Q3 EPS (13c), consensus (18c) »

Reports Q3 revenue $7.6M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 12

    Nov

KDMN

Kadmon

$2.99

-0.025 (-0.83%)

16:28
11/11/19
11/11
16:28
11/11/19
16:28
Hot Stocks
Kadmon's KD025 met primary endpoint in interim pivotal trial analysis of KD025 »

Kadmon Holding announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVKIF

Evonik

$0.00

(0.00%)

16:27
11/11/19
11/11
16:27
11/11/19
16:27
Upgrade
Evonik rating change  »

Evonik upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.